Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, NHS, Novartis, pharma

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

News
novartis_window

Novartis strike $40m deal with Chinese firm Cellular Biomedicine

September 28, 2018
Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc

Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …

News
gilead-sciences

Gilead to release generic versions of hep C meds over a decade before patent expiry

September 28, 2018
Medical Communications, Sales and Marketing Epclusa, Gilead, generics, harvoni, hepatitis C, pharma

Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …

News
cow_field_farm_nature_agriculture_green_meadow_animal-1278036

UK government accused of using Brexit to avoid antimicrobial resistance ruling

September 28, 2018
Medical Communications AMR, Antibiotics, UK, WHO, antimicrobial resistance, farming, politics

The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be …

News
darpa_big_data

Percentage of life sciences professionals using blockchain has tripled since 2017

September 27, 2018
Medical Communications blockchain, pharma, pistoia alliance, technology

A survey conducted by The Pistoia Alliance, a not-for-profit coalition of life science companies, vendors, publishers and academic groups, has …

News
shutterstock_273326141

Novartis joins forces with GARDP for better, accessible infectious disease treatments in the developing world

September 27, 2018
Research and Development, Sales and Marketing GARDP, Novartis, infectious disease, pharma

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …

News
mosquito-1016254_1280

Researchers eliminate mosquito population through CRISPR gene editing technology

September 27, 2018
Research and Development crispr, gene editing, imperial college london, malaria, mosquitoes

Researchers at Imperial College London have been able to wipe out a population of mosquitoes through ‘gene drive’ technology. The …

News
life_sciences_scotland_edit

Life Sciences Scotland appoints two MSPs to their Industry Leadership Group

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma

Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …

Appointment
kenneth_c

Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma

MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …

News
28246711066_52e38bc591_z

EMA says pharma industry now more prepared for Brexit

September 27, 2018
Manufacturing and Production, Medical Communications EMA, EU, brexit, products, qppv

In July of this year the European Medicines Agency (EMA) identified significant gaps in the pharmaceutical industry’s preparedness for Brexit. …

News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …

News
alexion_sign

Alexion’s Soliris almost entirely eliminates relapses in rare neuromyelitis optica spectrum disorder

September 26, 2018
Research and Development Alexion, neuromyelitis optica spectrum disorder, pharma, rare disease, soliris

Alexion has revealed new Phase 3 findings for Soliris (eculizumab), showing the drug met its primary endpoint in the treatment …

News
takeda_usa_pharmaceuticals_u

Takeda’s lung cancer treatment Alunbrig proves successful in Phase III trial

September 26, 2018
Research and Development Alunbrig, R&D, Takeda, phase III, research

Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …

News

Roche’s Tecentriq+chemo combo shows first-line benefit in small cell lung cancer

September 26, 2018
Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq

Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …

News
glasgow-2997986_960_720

Life expectancy falls in Scotland for first time in 35 years

September 26, 2018
Research and Development Scotland, UK, health, life expectancy, uk politics

Life expectancy has fallen for the first time in 35 years in Scotland, as data released by the National Records …

News
astrazeneca_plaque

AstraZeneca CEO suggests he’s the ‘lowest paid CEO in the whole industry’ as he raises concerns surrounding Brexit

September 25, 2018
Business Services, Research and Development

Pascal Soriot, the Chief Executive Officer of the Anglo-Swedish multinational AstraZeneca, has raised concerns that he is being underpaid, despite …

News
white-blood-cell-543471_1920

NICE decision could limit future development of CAR T therapies; Evelyn Warner comments on NICE’s decision making process

September 25, 2018
Research and Development CAR T, CAR-T, Cancer, Duff and Phelps, Kymriah, access, oncology, pricing

Lack of access to CAR T therapies in the United Kingdom could hinder the development of effective personalised cancer treatments, …

News
29496564944_a9faceb1c2_z

President Trump pledges to fight drug addiction at UN meeting

September 25, 2018
Manufacturing and Production Trump, UN, drugs, illicit drugs, trafficking

President Donald Trump has pledged to fight “the scourge of drug addiction,” as he outlined his commitment to the fight …

News

Roche’s entrectinib shrinks lung tumours with two-year response duration

September 25, 2018
Manufacturing and Production, Research and Development, Sales and Marketing Cancer, NSCLC, NSCLC< lung cancer, Roche, entrectinib

Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive …

News
jj_sign_on_wall

J&J pledges to end global TB pandemic

September 25, 2018
Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis

Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026